United StatesUterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
What it does
This bill authorizes grants to support early detection of and intervention for uterine fibroids. Uterine fibroids are tumors in the wall of the uterus that are usually benign but can cause painful and heavy menstrual bleeding and other symptoms.
More detail
The bill requires the Department of Health and Human Services (HHS) to (1) conduct or support research on increasing early detection of and medical intervention for uterine fibroids, and (2) formulate strategies to increase early detection based on such research.
Also, the bill authorizes HHS to provide grants to states to increase early detection of and intervention for uterine fibroids (e.g., screenings) and to carry out public awareness campaigns. Additionally, the bill authorizes HHS to provide grants to states for research relating to (1) disparities in pain management in uterine fibroid surgical treatment; or (2) uterine health conditions, as determined appropriate by HHS.
HHS must report to Congress every two years on the activities funded by grants under the bill, including findings from the research conducted by states.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Mar 19Committee on Health, Education, Labor, and Pensions. Hearings held.Latest
- 2025
- Jul 30Introduced in Senate
- Jul 30Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Introduced